Edwards Lifesciences Corp. buy JPMorgan Chase & Co.
Start price
18.12.25
/
50%
€72.35
Target price
18.12.26
€85.19
Performance (%)
-2.90%
Price
02.04.26
€70.25
Summary
This prediction is currently active. With a performance of -2.90%, the BUY prediction by JPMorgan_Chase___Co_ is trending in the wrong direction. This prediction currently runs until 18.12.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Edwards Lifesciences Corp. | -1.445% | -1.445% |
| iShares Core DAX® | 2.489% | -5.941% |
| iShares Nasdaq 100 | 1.649% | -2.462% |
| iShares Nikkei 225® | 0.555% | -7.597% |
| iShares S&P 500 | 1.347% | -2.943% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Edwards Lifesciences Corp. diskutieren
Edwards Lifesciences (NYSE:EW) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $100.00 price target on the stock, up previously from $90.00.
Ratings data for EW provided by MarketBeat